Aug 2026· ACS Medicinal Chemistry Letters· Vol 17, pp. 2153-2159· 0 citations· 37 references
TL;DR
These findings identify tryptophan-functionalized [60]fullerene as a promising multivalent scaffold for SARS-CoV-2 protein targeting.
Abstract
Water-soluble fullerene derivatives represent emerging molecular nanomaterials for antiviral drug discovery, yet their target selectivity against SARS-CoV-2 proteins remains insufficiently defined. Here, four functionalized [60]fullerenes, C60(OH)24, C60ser, C60ALA, and C60Trp, were evaluated as binders of key SARS-CoV-2 targets involved in viral entry and replication: spike glycoprotein, papain-like protease, 3CL main protease, and RNA-dependent RNA polymerase. Microscale thermophoresis revealed distinct target-dependent binding profiles governed by fullerene functionalization. The C60Trp fullerene was the most active derivative, binding Spike with nanomolar affinity (Kd = 94.8 nM) and showing micromolar affinity toward papain-like protease and 3CL main protease. Docking and molecular dynamics simulations supported the preferential interaction of C60Trp with the spike protein cavity through combined fullerene cage complementarity and polar interactions with lysine and arginine residues. The tested derivatives showed low cytotoxicity in A549 cells, and C60Trp was efficiently internalized. These findings identify tryptophan-functionalized [60]fullerene as a promising multivalent scaffold for SARS-CoV-2 protein targeting.
This study provides binding details for the designed compounds and demonstrates the feasibility of the joint X-ray/neutron structure-assisted drug design approach to generate more potent noncovalent nonpeptidic SARS-CoV-2 MPro inhibitors.
Dipendra Bhandari, Katerina Kovalevskaya, L. Coates et al.· RSC Medicinal Chemistry· 0 citations
The SARS-CoV-2 main protease (Mpro) plays a crucial role in viral replication, making it an attractive target for antiviral drug development. This study evaluates the inhibitory potential of nineteen 6-substituted coumarin derivatives (1a–p and 2a–c) against Mpro using a FRET-based enzymatic assay. Among them, the chlo...
Ashraf K. El-Damasy, Md Sofequl Islam Mukim, Sangeun Jeon et al.· RSC Advances· 0 citations
Although several SARS-CoV-2 main protease (Mpro) inhibitors have been clinically authorized, the continued evolution of SARS-CoV-2 and the emergence of resistance-associated mutations highlight the need for additional inhibitor scaffolds with balanced potency, chemical stability, and reversible covalent reactivity. Her...
Peng-Yao Jin, Yang-Jie Zeng, Zhi-Dan Fan et al.· Bioorganic chemistry (Print)· 0 citations
In this study, half-sandwich Ru(II)-p-cymene complexes containing L-borneol-based biguanide ligands were synthesized, characterized and evaluated for their biological properties. Lipophilicity (logP) and hydrolysis studies demonstrated that the biguanide moiety and its substituents significantly influence hydration beh...
Abdulmecit Gul, Hüsne Gülseren Kalay, Julide Nacaroğlu Ballı et al.· Journal of Inorganic Biochem...· 0 citations
Polyoxometalates (POMs) are promising antiviral agents, yet systematic structure–activity relationships remain scarce and biological stability is rarely assessed. Here we report the antiviral activity, cytotoxicity, and solution speciation of 11 Keggin-type POMs spanning three compositional seriesPV x W12–x , PV x Mo1...
Judith Füllborn-Ott, Aliona Dobrova, N. Gumerova et al.· Journal of Medicinal Chemist...· 0 citations
BACKGROUND
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, results in severe acute respiratory illness and has been declared a global public health emergency. Developing effective therapeutic strategies to control the infection remains an urgent priority. The viral spike glycoproteins and proteases play crucial...
Aakrshit Singh, Gaurav Krishna, Shilpi Sonker et al.· Current Organic Synthesis· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.